Farther Finance Advisors LLC Cuts Holdings in Agilent Technologies, Inc. (NYSE:A)

Farther Finance Advisors LLC lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 8.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,811 shares of the medical research company’s stock after selling 178 shares during the quarter. Farther Finance Advisors LLC’s holdings in Agilent Technologies were worth $207,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Flynn Zito Capital Management LLC grew its position in Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after acquiring an additional 69 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 69 shares in the last quarter. Tiemann Investment Advisors LLC boosted its stake in shares of Agilent Technologies by 5.6% in the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after purchasing an additional 75 shares in the last quarter. Rothschild Investment LLC raised its position in Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after purchasing an additional 79 shares during the period. Finally, CIBC Private Wealth Group LLC lifted its stake in Agilent Technologies by 1.2% in the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock worth $1,025,000 after purchasing an additional 87 shares during the last quarter.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the company’s stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This represents a 4.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Stock Down 0.4%

A opened at $115.62 on Friday. The stock has a market capitalization of $32.84 billion, a price-to-earnings ratio of 28.55, a PEG ratio of 3.51 and a beta of 1.23. The firm has a 50 day moving average price of $110.41 and a 200-day moving average price of $124.86. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm’s revenue was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Tuesday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 24.44%.

Wall Street Analyst Weigh In

Several research firms have issued reports on A. Jefferies Financial Group cut their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating for the company in a research report on Monday, April 21st. Barclays lowered their target price on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. Wells Fargo & Company reduced their price target on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Leerink Partners lifted their price target on Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Friday, May 30th. Finally, JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating for the company in a research note on Thursday, May 29th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies has an average rating of “Hold” and a consensus target price of $140.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.